Insider Shareholders with Direct Ownership of Terns Pharmaceuticals, Inc. (TERN)
This section provides a comprehensive overview of the insiders with direct ownership of Terns Pharmaceuticals, Inc. (TERN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Terns Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Seokho Bryan Yoon
COO and General Counsel |
91,940 | 0 | 91,940 $423,843 | 6 |
May 31, 2024
Added 4.95%
|
|
Erin Quirk
President, Head of R&D |
75,000 | 0 | 75,000 $345,750 | 1 |
Jan 23, 2024
Added 50.0%
|
|
Mark J. Vignola
Chief Financial Officer |
101,940 | 27,188 | 74,752 $344,606 | 10 |
Jan 06, 2025
Reduced 10.81%
|
|
Emil Kuriakose
Chief Medical Officer |
0 | 4,481 | 54,269 $250,180 | 1 |
Jan 02, 2025
Reduced 7.63%
|
|
Amy L. Burroughs
Chief Executive Officer |
15,450 | 0 | 19,099 $88,046 | 1 |
Dec 05, 2024
Added 44.72%
|
|
Senthil Vel Sundaram
Chief Executive Officer |
9,770 | 0 | 9,770 $45,039 | 3 |
May 31, 2023
Added 17.77%
|
| 62,000 | 62,000 | 0 $0 | 12 |
Jan 06, 2025
Reduced 100.0%
|